Literature DB >> 61905

Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis.

A M Cochrane, A Moussouros, A Smith, A D Thomson, A L Eddleston, R Williams.   

Abstract

Lymphocyte cytotoxicity for isolated hepatocytes has been demonstrated in 93% of cases of acute viral hepatitis tested within two weeks of the onset of symptoms. The frequency of cytotoxicity during this time was similar for HBsAg positive and negative cases. However, after this time it was significantly higher in HBsAg positive than negative cases, 90% and 25% respectively (P less than 0-01). Cytotoxicity was found in B-cell, but not T-cell, enriched fractions of lymphocytes, compatible with an antibody-dependent K-cell mediated reaction. In two cases the assay remained positive on retesting six months later, and follow-up liver biopsies showed the features of chronic aggressive hepatitis. These findings suggest that, in addition to the known immunological reactions against viral antigens that occur during the acute phase of viral hepatitis, an autoimmune reaction directed against a liver specific protein is also initiated; and if this reaction persists then chronic hepatitis may develop.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61905      PMCID: PMC1411272          DOI: 10.1136/gut.17.9.714

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

2.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

Authors:  K H Meyer zum Büschenfelde; U Hopf
Journal:  Br J Exp Pathol       Date:  1974-10

4.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

5.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

6.  Letter: HBAg on liver-cell surface in viral hepatitis.

Authors:  A Alberti; G Realdi; F Tremolada; P Cadrobbi
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

7.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

Review 8.  Immunopathology of viral hepatitis in man.

Authors:  W D Reed; A L Eddleston; R Williams
Journal:  Prog Med Virol       Date:  1974

9.  Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit.

Authors:  R M Galbraith; A L Eddleston; B Portmann; R Williams; P E Gower
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

10.  Clinical and serological analysis of transfusion-associated hepatitis.

Authors:  H J Alter; P V Holland; A G Morrow; R H Purcell; S M Feinstone; Y Moritsugu
Journal:  Lancet       Date:  1975-11-01       Impact factor: 79.321

View more
  12 in total

1.  [Lymphocyte toxicity in viral hepatitis].

Authors:  L J Hao; S X Shi
Journal:  Acta Acad Med Wuhan       Date:  1984

Review 2.  The immunopathology of acute type B hepatitis.

Authors:  L Bianchi
Journal:  Springer Semin Immunopathol       Date:  1981-04

3.  Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificity.

Authors:  C I Smith; W G Cooksley; L W Powell
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

4.  Study of cellular immunity in experimental autoimmune hepatitis in mice.

Authors:  Y Mori; T Mori; H Yoshida; S Ueda; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.

Authors:  Y Mori; T Mori; S Ueda; H Yoshida; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.

Authors:  L Ortona; V Laghi; R Cauda; P Nervo
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

7.  Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.

Authors:  F Bortolotti; G Realdi; G Diodati; G Fattovich
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

8.  Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.

Authors:  R Meliconi; M Baraldini; G F Stefanini; A Facchini; F Miglio; F Bortolotti; A Alberti; G Realdi; P Amoroso
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

9.  Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.

Authors:  C Feighery; G S McDonald; J F Greally; D G Weir
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis.

Authors:  T H Hütteroth; T Poralla; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.